This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Telix Pharmaceuticals is expanding its theranostic pipeline with newly acquired assets targeting fibroblast activation protein (FAP) in nuclearmedicine. These were developed by Frank Roesch, PhD, and colleagues at the Institute of Nuclear Chemistry at the Johannes Gutenberg-Universität Mainz, Germany.
ChatGPT shows potential for diagnosing nuclearmedicine cases, yet needs further development before it can be implemented in practice, according to a study presented November 28 at RSNA in Chicago. and ChatGPT-4 to the test on nuclearmedicine differential diagnoses cases transcribed from two textbooks.
TORONTO – Clinician-scientists can do much to advance nuclearmedicine, but it will take passion and stamina to succeed, said Ora Israel MD, at the annual meeting of the Society of NuclearMedicine and Molecular Imaging (SNMMI). Clinical research involves a different perspective. Wagner Lecture on June 7.
The American College of Radiology (ACR) is asking for feedback on its draft nuclearmedicine quality control manual. The manual is designed to help facilities establish and maintain an effective nuclearmedicine quality control program and meet the requirements of ACR’s NuclearMedicine Accreditation Program (NMAP).
The recommendations could improve patient care, as current clinical tools are often insufficient in complicated cases, noted lead author of the guidance Jamieson Bourque, MD, of the University of Virginia Health System in Charlottesville. The recommendations emphasize the complementary nature of these advanced nuclearmedicine exams.
Thus, the researchers aimed to determine prospectively whether 18F-FES PET improves staging for patients with clinical stage II/III or local-regional recurrent, grade 1 or 2, ER-positive breast cancer compared with standard F-18 FDG-PET. The full study is available here.
The finding is from a preliminary analysis of 23 patients enrolled in an ongoing clinical trial, noted Giorgio Brembilla, MD, PhD, of the IRCCS San Raffaele Scientific Institute in Milan, Italy. The combination of PSMA-PET and MRI could improve the detection of clinically significant cancer in clinically high-risk patients, he concluded.
The study was published February 13 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine. Thus, with further development in larger trials, Ga-68 FZ-NR-1 could play a significant clinical role, they suggested.
and European experts have proposed a joint practice guideline for use in nuclearmedicine on diagnostics and therapy (theranostics) of meningiomas, as published June 20 in the European Journal of NuclearMedicine and Molecular Imaging. the group wrote. or European medical agencies, they added.
We highlight some of the recent accomplishments in research and clinical trials by members of the department who apply nuclearmedicine to diagnose and treat illnesses including cancer.
PET/CT imaging using gallium-68 (Ga-68) Fibroblast activation protein inhibitor (FAPI) radiotracer over F-18 FDG appears promising in women with invasive lobular carcinoma (ILC), according to a study published March 14 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
The world’s top nuclearmedicine societies have issued international guidelines on the role of PET/CT in patients with invasive ductal carcinoma breast cancer, with the document released May 14 in the European Journal of NuclearMedicine and Molecular Imaging.
Most Influential Radiology Researcher Erik Middlebrooks, MD, Mayo Clinic, Jacksonville, FL Erik Middlebrooks, MD. One of this year's nominations for Most Influential Radiology Researcher is Erik Middlebrooks, MD, of the Mayo Clinic in Jacksonville, FL.
Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclearmedicine, diagnostic radiology, and radiation oncology.
With strong demand for medical imaging in many differing clinical contexts, hospitals are managing growing routine imaging demands while balancing teaching practices, ambulatory services, primary care, and subspecialty services. billion healthcare facility. Another, a new hospital complex is underway at University of Utah Health.
The article was published October 10 in the Journal of NuclearMedicine. Overall, these developments have led to an increase in the use of SSTR-directed PET imaging and therapy in routine clinical practice and its integration into clinical trials,” the authors wrote.
Middlebrooks, MD, Mayo Clinic, Jacksonville, FL Erik H. Middlebrooks, MD, of the Mayo Clinic in Jacksonville, FL. Given the extensive array of sequences and techniques employed in clinical imaging, we must address the inherent challenges associated with each," he noted. Middlebrooks, MD.
As nuclearmedicine therapies gain stature compared to nuclearmedicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. A shortage of nuclearmedicine technologists means a theranostics center may need to limit its patient volume.
PET/CT imaging with F-18 fluroestradiol (FES) can play a significant role helping clinicians make treatment decisions in patients with recurrent or metastatic breast cancer, according to a study published October 3 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
Positron provides PET and PET-CT imaging systems and clinical services to nuclearmedicine healthcare providers throughout North America. Offering both anatomic and functional imaging, NeuSight PET-CT supports a wide range of molecular imaging applications, according to the company.
Fibroblast activation protein inhibitor (FAPI)-PET/CT appears superior to standard FDG-PET/CT for detecting gastrointestinal cancer, with higher radiotracer uptake seen in most tumors, according to a study published October 26 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
Researchers at the University of Zurich in Switzerland say they have produced the first cinematically rendered image from a patient based on a standard clinical F-18 FDG-PET/MRI scan. The article was published on July 1 in the European Journal of NuclearMedicine and Molecular Imaging and featured as the journal's Image of the Month.
We highlight some of the recent accomplishments in research and clinical trials by members of the department who apply nuclearmedicine to diagnose and treat illnesses including cancer.
They're also mindful of the multiple dedicated teams required to build a theranostics clinic properly. Hope, vice chair of clinical operations and strategy in the UCSF department of radiology, established the radioligand therapy group at the university. Theranostics is becoming a treatment option for a larger volume of cancer patients.
In a study published April 17 in ClinicalNuclearMedicine , the group at Brigham tested a new TSPO radiotracer they developed for visualizing such activity called F-18 PBR06. Image courtesy of ClinicalNuclearMedicine. The full article is available here.
milla1cf Tue, 06/11/2024 - 18:49 June 11, 2024 — The Society of NuclearMedicine and Molecular Imaging recognized six new SNMMI Fellows during a plenary session at the society’s 2024 Annual Meeting, held June 8-11 in Toronto. It is among the most prestigious formal recognitions available to long-time SNMMI members.
FAPI-PET imaging could emerge as a new tool for assessing patients with single pulmonary tumors, especially in those with negative results on other scans, according to a study published April 11 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine. “In
New imaging and treatment strategies are emerging to prolong the lives of men with metastatic castration-resistant prostate cancer (mCRPC), according to a presentation at the recent Society of NuclearMedicine and Molecular Imaging (SNMMI) annual meeting. Now there’s Pluvicto, she said.
In a comparative imaging trial, fibroblast activation protein inhibitor (FAPI)-PET/CT outperformed FDG-PET/CT in detecting primary tumors in patients with head and neck cancer, according to a study published January 25 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
FAPI-PET imaging may become a powerful diagnostic tool for detecting pancreatic cancer, according to a study published November 16 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine. In this study, the researchers analyzed data on 62 patients with suspected pancreatic cancer.
Medical students prefer musculoskeletal, body, and breast imaging early in their clinical education, according to research published October 19 in Current Problems in Diagnostic Radiology. 0.048 NuclearMedicine 5.1% 0.037 Pediatric radiology 28.8% 0.001 Body imaging 30.2% 0.034 Neuroradiology 19.5%
F-18 FAPI-PET/CT is superior to F-18 FDG-PET/CT for diagnosing and staging patients with pancreatic cancer, according to a study published January 4 in the Journal of NuclearMedicine. In the future, F-18 FAPI-04 PET/CT may play a greater role in the actual clinical management of PDAC,” the group wrote.
“This is a potentially practice-changing trial,” said Oliver Sartor, MD, a medical oncologist and director of radiopharmaceutical trials at the Mayo Clinic in Rochester, MN. He presented the abstract on behalf of first author Ken Herrmann, MD, chair of nuclearmedicine at the University Hospital Essen in Essen, Germany.
A new PET/CT radiotracer that detects insulinomas could eliminate the need for other diagnostic procedures in a vast majority of patients, according to a study published October 17 in the Journal of NuclearMedicine. International) and courtesy of the Journal of NuclearMedicine. DEED, Attribution 4.0
An emerging PET/CT radiotracer may be more predictive of progressive pulmonary fibrosis in interstitial lung patients than F-18 FDG PET/CT, according to research presented June 8 at the 2024 Society of NuclearMedicine and Molecular Imaging Annual Meeting (SNMMI). Comparative analysis involved PET/CT parameters of both tracers.
PET/CT imaging with F-18 sodium fluoride (NaF) is emerging as a sensitive tool for detecting early atherosclerosis, according to a presentation at the recent Society of NuclearMedicine and Molecular Imaging (SNMMI) annual meeting. The patients ranged in age from 21 to 75 years old.
Pluvicto (lutetium-177 [Lu-177] prostate-specific membrane antigen [PSMA]-617) appears to perform as effectively in prostate cancer patients in “real-world” settings as it did in clinical trials prior to its approval, according to clinicians at the Johns Hopkins Theranostics Center in Baltimore, MD.
A new PET radiotracer has the potential for visualizing responses in liver cancer patients undergoing immunotherapy, according to a study published December 12 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine. Nuclei were stained with 4,6-diamidino-2-phenylindole.
the RSNA Mahmood's primary research for the past 30 years has been in molecular imaging and its application to guide precision medicine. At MGH in Boston, he currently serves as chief of nuclearmedicine and molecular imaging, overseeing the service for multiple hospitals and facilities in the region. Umar Mahmood, MD, PhD.
PET/CT imaging with a new gallium-68-based prostate cancer radiotracer shows promise for detecting recurrent metastatic disease, according to a study published February 20 in the Journal of NuclearMedicine. The finding is from a phase I/II clinical trial in the U.S. HU = Houndsfield unit; SUVbw = body-weight SUV.
Also, two-thirds of the studies focused on staff in diagnostic radiography, with the rest covering radiation therapy, medical sonography, and nuclearmedicine. A [workplace violence] policy should be developed in every clinical workplace," the authors concluded.
PET/MRI scans have revealed immune system reactions after COVID-19 vaccines in children with cancer, according to a study published October 26 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine. The mean SUV max increased by a factor of three, from 0.87 before before vaccination to 2.61 after
“We show that triggering of seizures with direct electric stimulation for ictal SPECT imaging is convenient, spares resources, and can be clinically useful,” the group wrote. The article was published January 11 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
A recently developed PET radiotracer identified sources of pain in patients with complex regional pain syndrome (CRPS) and led to effective treatments, according to a study presented June 10 at the Society of NuclearMedicine and Molecular Imaging (SNMMI) annual meeting. To that end, Baal and colleagues developed F-18 FTC-146.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content